CUSIP: 586858102
Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,417,446
-
Share change
-
+15,417,446
-
Total reported value
-
$579,384,292
-
Price per share
-
$37.58
-
Number of holders
-
49
-
Value change
-
+$579,384,292
-
Number of buys
-
49
Quarterly Holders Quick Answers
What is CUSIP 586858102?
CUSIP 586858102 identifies MNLO - MENLO THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 586858102:
Institutional Holders of MENLO THERAPEUTICS INC - COM (MNLO) as of Q1 2018
As of 31 Mar 2018,
MENLO THERAPEUTICS INC - COM (MNLO) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,417,446 shares.
The largest 10 holders included
Vivo Capital, LLC, JANUS HENDERSON GROUP PLC, PERCEPTIVE ADVISORS LLC, venBio Partners L.P., Novo Holdings A/S, FMR LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and VHCP Management II, LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.